Salta al contenuto principale
Passa alla visualizzazione normale.

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Studi Osservazionali 2022

Ascolta

 

Title Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & Validation of Imaging Modality Performance Across the NAFLD Spectrum in a Prospectively Recruited Cohort
NCT Number NCT05479721
IRAS ID 250344
18/LO/1953 (Other Identifier: NHS Health Research Authority)
Conditions NAFLD

NASH

NASH - Nonalcoholic Steatohepatitis

Fibrosis, Liver

Steatosis of Liver
Interventions  
Sponsor/Collaborators University of Oxford
Gender All
Age 18 Years to 100 Years   (Adult, Older Adult)
Phases  
Enrollment 450 participants
Study Type Observational
Study Designs Cohort
Start Date 04/09/2019
Completion Date 31/10/2022
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. Gastroenterologia, prof. Salvatore Petta
URL https://www.clinicaltrials.gov/ct2/show/NCT05479721 

 

Title Retrospective Observational Study on Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections - DALBADIA Study
NCT Number NCT04959799

146(Z)PO20094

Conditions Intervention/treatment 

Diabetes

Infection
Interventions Drug: Dalbavancin
Sponsor/Collaborators Aziende Chimiche Riunite Angelini Francesco S.p.A
Gender All
Age 18 Years and older   (Adult, Older Adult)
Phases  
Enrollment 98
Study Type Observational
Study Designs Cohort
Start Date 02/01/2022
Completion Date 31/05/2022
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Malattie Infettive, Prof. Antonio Cascio
URL https://www.clinicaltrials.gov/ct2/show/NCT04959799 

 

Title A Multicenter, Non-Interventional Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Patients With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
NCT Number NCT04165135
Conditions Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor

Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor

Haemophilia A
Interventions Drug: Standard of Care for Haemophilia A
Sponsor/Collaborators Hoffmann-La Roche
Gender All
Age 12 Years to 50 Years   (Child, Adult)
Phases  
Enrollment 107
Study Type Observational
Study Designs Cohort
Start Date 24/02/2020
Completion Date 28/04/2022
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa
URL https://www.clinicaltrials.gov/ct2/show/NCT04165135 

   


Studi Osservazionali – Anno 2022

Data

Titolo

Docente/i del Dipartimento

01/01/2022

Pneumococcal carriage in Sicily in the pre-COVID-19 era: a retrospective study over a 5-year period

Fabio Tramuto

01/01/2022

Progetto in collaborazione con la European Medicine Agency e l’Università degli Studi di Verona “Covid19-Vaccine-Monitor”

Claudio Costantino (Francesco Vitale – Ilaria Morreale)

01/01/2022 - 31/12/2022

Studio dal titolo: LIPIGEN (Lipid TransPort Disorders italian Genetic Network)

Proff. Maurizio Averna e Angelo Baldassare Cefalù

01/01/2022 - 31/12/2022

Studio dal titolo: HOFH, THE INTERNATIONAL CLINICAL COLLABORATORS (HICC) A GLOBAL HOFH DATA-SHARING PLATFORM

Proff. Maurizio Averna e Angelo Baldassare Cefalù

01/01/2022 - 31/12/2022

Registro dal titolo: LOWER: Lomitapide Observational Worldwide Evaluation Registry

Proff. Maurizio Averna e Angelo Baldassare Cefalù

14/04/2022

“Observational study on GUselkumab: effectiveness and impact on quaLity of LIfe in naïVE or bio experienced patients with Regional (facial and genital)” – Studio GULLIVER Prot. CNTO1959PSO4013

Prof.ssa Maria Rita Bongiorno e Prof. Giuseppe Pistone

14/04/2022

SERENA Study: Long-term observational, prospective study to collect in a real life setting data on the retention, effectiveness, safety, treatment pattern, quality of life, and efficiency of secukinumab in adult patients with moderate to severe plaque psoriasis, psoriatic arthritis or ankylosing spondylitis – Prot. CAIN457A3403

Prof.ssa Maria Rita Bongiorno e Prof. Giuseppe Pistone

30/06/2022

Confronto di efficacia tra dapagliflozin ed farmaci ipoglicemizzanti (non insulina, non altri SGLT2 inibitori) su endpoints renali nel diabete tipo 2. Studio real-world multicentrico italiano – DARWIN-Renal

Prof. Roberto Citarrella

30/06/2022

Progetto: LIFE FOOD DIET : CERTIFICAZIONE DI SISTEMA

Prof. Alberto Firenze

30/06/2022

Progetto: Stress lavoro correlato

Prof. Alberto Firenze

30/06/2022

Progetto: APP. i VIAGGIO

Prof. Alberto Firenze

30/06/2022

Progetto: INDOOR

Prof. Alberto Firenze

30/06/2022

Progetto: Safety Walk Round

Prof. Alberto Firenze

30/06/2022

Progetto: Educazione alla vita

Prof. Alberto Firenze

30/06/2022

Progetto: Hospital Chef

Prof. Alberto Firenze

30/06/2022

Progetto: Serve una mano?

Prof. Alberto Firenze

30/06/2022

Progetto: Quater sicurezza del paziente: sviluppo e implementazione della rete dei risk manager nella regione Sicilia

Prof. Alberto Firenze

30/06/2022

Progetto: Audit civico

Prof. Alberto Firenze

30/06/2022

Registro Nazionale Malattie Rare

Prof.ssa Giuliana Guggino

30/06/2022

Registro GIRRCS: valutazione efficacia switch secukinumab – ixekizumab

Prof.ssa Giuliana Guggino

30/06/2022

sjogren syndrome…

Prof.ssa Giuliana Guggino

30/06/2022

Registro GIRRCS SAK INHIBITORS

Prof.ssa Giuliana Guggino

30/06/2022

Psoriatie arthrims observational study of persistence of treatment (pro-spirit study)

Prof.ssa Giuliana Guggino

30/06/2022

Studio osservazionale prospettivo …..

Prof.ssa Giuliana Guggino

30/06/2022

Studio osservazionale non interventistico…

Prof.ssa Giuliana Guggino

30/06/2022

Tasso di resistenza in terapia di anakinra …..

Prof.ssa Giuliana Guggino

30/06/2022

START:…..

Prof.ssa Giuliana Guggino

30/06/2022

Registro italiano di Fibromialgia

Prof.ssa Giuliana Guggino